Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates


Drug resistance in carbapenem-resistant enterobacteriaceae infections: case report.

    • 4 Accesses

    This is a preview of subscription content, log in to check access.


    1. Ackley R, et al. Recurrence of infection and emergence of drug resistance after treatment with meropenem/vaborbactam compared with ceftazidime/avibactam in carbapenem-resistant enterobacteriaceae infections. Open Forum Infectious Diseases 6 (Suppl. 2): S303 abstr. 662, Oct 2019. Available from: URL: http://doi.org/10.1093/ofid/ofz360.730 [abstract]

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Meropenem/vaborbactam. Reactions Weekly 1791, 168 (2020). https://doi.org/10.1007/s40278-020-75013-9

    Download citation